Aveo Pharmaceuticals suffers new setback as Japanese partner backs away from plan to seek European approval of Aveo’s kidney cancer drug
24 May 2013
Aveo Pharmaceuticals Inc., already reeling from an advisory panel recommendation early this month that US regulators reject its kidney cancer drug, has suffered a new setback. Full News here – businessupdates













